September 13, 2011 — A class I recall has been issued for certain Medtronic implantable programmable infusion pumps (SynchroMed II), the US Food and Drug Administration (FDA) announced yesterday.

Much of Medtronic’s work in diabetes this year has focused specifically on bringing new technologies to European patients—and its latest purchase continues this trend. The medtech giant snapped up the ...

The thin plastic tubing of infusion sets that connect insulin pumps to the body typically need to be changed every two or three days—but a new version in the U.S. more than doubles that timespan. The ...